BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27425425)

  • 1. Anti-Ro/SSA antibodies are associated with severe mitral valve regurgitation in patients with systemic lupus erythematosus.
    Higuera-Ortiz V; Mora-Arias T; Castillo-Martinez D; Amezcua-Guerra LM
    Mod Rheumatol; 2017 May; 27(3):476-480. PubMed ID: 27425425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
    Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
    ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus.
    Novak GV; Marques M; Balbi V; Gormezano NW; Kozu K; Sakamoto AP; Pereira RM; Terreri MT; Magalhães CS; Guariento A; Sallum AM; Marini R; Ferriani VP; Barbosa CM; de Castro TC; Ramos VC; Bonfá E; Silva CA
    Autoimmun Rev; 2017 Feb; 16(2):132-135. PubMed ID: 27988434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
    Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
    Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype.
    Peene I; Meheus L; Veys EM; De Keyser F
    Ann Rheum Dis; 2002 Dec; 61(12):1090-4. PubMed ID: 12429541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
    Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA/Ro and to SSB/La.
    Franceschini F; Cretti L; Quinzanini M; Rizzini FL; Cattaneo R
    Lupus; 1994 Oct; 3(5):419-22. PubMed ID: 7841997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies.
    Provost TT; Reichlin M
    J Am Acad Dermatol; 1981 Jan; 4(1):84-9. PubMed ID: 6970760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical & immunological characteristics in systemic lupus erythematosus patients.
    Rastin M; Mahmoudi M; Sahebari M; Tabasi N
    Indian J Med Res; 2017 Aug; 146(2):224-229. PubMed ID: 29265023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.
    Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA
    Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence on pregnancy of anti-SSA/Ro antibodies in systemic lupus erythematosus.
    Leu LY; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):12-20. PubMed ID: 1306146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
    Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
    Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.